Cormorant Asset Management

Latest statistics and disclosures from Cormorant Asset Management's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are PRAX, BBOT, ABVX, QQQ, EYPT, and represent 45.80% of Cormorant Asset Management's stock portfolio.
  • Added to shares of these 9 stocks: QQQ (+$154M), IWM (+$123M), XBI (+$122M), OLMA (+$69M), MLTX (+$31M), ASND (+$21M), ENGN (+$15M), ALMS (+$15M), COGT (+$8.0M).
  • Started 6 new stock positions in XBI, ASND, QQQ, IWM, COGT, OLMA.
  • Reduced shares in these 10 stocks: ABVX (-$81M), ACLX (-$64M), NAMS (-$41M), INSM (-$27M), CGON (-$25M), KRRO (-$22M), MTSR (-$21M), EWTX (-$18M), BBIO (-$15M), CNTA (-$15M).
  • Sold out of its positions in ACLX, RNA, BMEA, CGON, ELVN, KRRO, MTSR.
  • Cormorant Asset Management was a net buyer of stock by $133M.
  • Cormorant Asset Management has $2.2B in assets under management (AUM), dropping by 49.22%.
  • Central Index Key (CIK): 0001583977

Tip: Access up to 7 years of quarterly data

Positions held by Cormorant Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Cormorant Asset Management

Cormorant Asset Management holds 35 positions in its portfolio as reported in the December 2025 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Praxis Precision Medicines I Com New (PRAX) 12.9 $280M -5% 950k 294.74
 View chart
Bridgebio Oncology Therapeut Com New (BBOT) 10.4 $224M 18M 12.52
 View chart
Abivax Sa Sponsored Ads (ABVX) 8.4 $182M -30% 1.4M 134.85
 View chart
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ) 7.1 $154M NEW 250k 614.31
 View chart
Eyepoint Com New (EYPT) 7.0 $151M 8.3M 18.27
 View chart
Ishares Tr Russell 2000 Etf Put Option (IWM) 5.7 $123M NEW 500k 246.16
 View chart
Spdr Series Trust State Street Spd Put Option (XBI) 5.6 $122M NEW 1.0M 121.93
 View chart
Rapport Therapeutics (RAPP) 4.2 $92M -5% 3.0M 30.34
 View chart
Bridgebio Pharma (BBIO) 4.2 $92M -14% 1.2M 76.49
 View chart
Bright Minds Biosciences Com New (DRUG) 3.8 $83M 1.1M 78.04
 View chart
Edgewise Therapeutics (EWTX) 3.8 $82M -18% 3.3M 24.82
 View chart
Olema Pharmaceuticals (OLMA) 3.2 $69M NEW 2.8M 25.00
 View chart
Moonlake Immunotherapeutics Class A Ord (MLTX) 2.7 $57M +118% 4.4M 13.18
 View chart
Insmed Com Par $.01 (INSM) 2.2 $48M -36% 275k 174.04
 View chart
Engene Holdings (ENGN) 1.7 $36M +72% 4.0M 9.03
 View chart
Alumis (ALMS) 1.6 $36M +69% 3.6M 9.76
 View chart
Mbx Biosciences (MBX) 1.6 $35M -8% 1.1M 31.54
 View chart
Newamsterdam Pharma Company Ordinary Shares (NAMS) 1.6 $35M -54% 1.0M 35.08
 View chart
Centessa Pharmaceuticals Sponsored Ads (CNTA) 1.5 $33M -31% 1.3M 25.01
 View chart
Pharvaris N V (PHVS) 1.4 $30M -20% 1.1M 27.75
 View chart
Bioage Labs (BIOA) 1.2 $27M -4% 2.0M 13.23
 View chart
Ascendis Pharma A/s Sponsored Adr (ASND) 1.0 $21M NEW 100k 213.24
 View chart
Tarsus Pharmaceuticals (TARS) 0.9 $21M -16% 250k 81.88
 View chart
Corbus Pharmaceuticals Hldgs Com New (CRBP) 0.9 $19M 2.3M 8.14
 View chart
Gh Research Ordinary Shares (GHRS) 0.8 $17M -32% 1.3M 12.70
 View chart
Oruka Therapeutics (ORKA) 0.7 $16M 533k 30.31
 View chart
Arcutis Biotherapeutics (ARQT) 0.7 $15M -35% 500k 29.04
 View chart
Crinetics Pharmaceuticals In (CRNX) 0.6 $14M -25% 300k 46.55
 View chart
Axsome Therapeutics (AXSM) 0.6 $14M -25% 75k 182.64
 View chart
Cabaletta Bio (CABA) 0.4 $9.6M -12% 4.4M 2.19
 View chart
Janux Therapeutics (JANX) 0.4 $9.0M -23% 650k 13.80
 View chart
Cogent Biosciences (COGT) 0.4 $8.0M NEW 225k 35.52
 View chart
Vaxcyte (PCVX) 0.3 $5.8M -28% 125k 46.14
 View chart
Amylyx Pharmaceuticals (AMLX) 0.2 $4.8M -20% 400k 12.08
 View chart
Biohaven (BHVN) 0.0 $113k 10k 11.29
 View chart

Past Filings by Cormorant Asset Management

SEC 13F filings are viewable for Cormorant Asset Management going back to 2013

View all past filings